Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine
Authors
Keywords
-
Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-03-04
DOI
10.1111/bjh.15818
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel approaches to acute myeloid leukemia immunotherapy
- (2018) Ofrat Beyar-Katz et al. CLINICAL CANCER RESEARCH
- DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer
- (2018) Na Luo et al. Nature Communications
- Demethylating agent decitabine disrupts tumor-induced immune tolerance by depleting myeloid-derived suppressor cells
- (2017) Jihao Zhou et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Harnessing the immune system in acute myeloid leukaemia
- (2016) Rebecca Austin et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions
- (2016) J. Rosenblatt et al. Science Translational Medicine
- Immune checkpoint blockade in hematologic malignancies
- (2015) P. Armand BLOOD
- DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts
- (2015) David Roulois et al. CELL
- Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
- (2015) Katherine B. Chiappinelli et al. CELL
- The immunosuppressive ligands PD-L1 and CD200 are linked in AML T-cell immunosuppression: identification of a new immunotherapeutic synapse
- (2015) S J Coles et al. LEUKEMIA
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Immunotherapy for Acute Myeloid Leukemia
- (2015) Felix S. Lichtenegger et al. SEMINARS IN HEMATOLOGY
- Hypomethylation and up-regulation of PD-1 in T cells by azacytidine in MDS/AML patients: A rationale for combined targeting of PD-1 and DNA methylation
- (2015) Andreas D. Ørskov et al. Oncotarget
- Unraveling the molecular pathways of DNA-methylation inhibitors: human endogenous retroviruses induce the innate immune response in tumors
- (2015) Reiner Strick et al. OncoImmunology
- Alterations of immune response of non-small cell lung cancer with Azacytidine
- (2015) John Wrangle et al. Oncotarget
- Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers
- (2015) Huili Li et al. Oncotarget
- Overcoming tumor-mediated immunosuppression
- (2014) Hans Anton Schlößer et al. Immunotherapy
- The targeting of immunosuppressive mechanisms in hematological malignancies
- (2014) M H Andersen LEUKEMIA
- Immunomodulatory action of SGI-110, a hypomethylating agent, in acute myeloid leukemia cells and xenografts
- (2014) Pragya Srivastava et al. LEUKEMIA RESEARCH
- The role of the immunosuppressive microenvironment in acute myeloid leukemia development and treatment
- (2014) Alessandro Isidori et al. Expert Review of Hematology
- Direct effect of dsRNA mimetics on cancer cells induces endogenous IFN-β production capable of improving dendritic cell function
- (2013) Gerardo Gatti et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- MHC Class I Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells
- (2013) P. Leone et al. JNCI-Journal of the National Cancer Institute
- Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
- (2013) H Yang et al. LEUKEMIA
- Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
- (2012) Hagop M. Kantarjian et al. JOURNAL OF CLINICAL ONCOLOGY
- Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemia
- (2012) Ellen K. Ritchie et al. LEUKEMIA & LYMPHOMA
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
- (2012) Li Ding et al. NATURE
- Studies of endogenous retroviruses reveal a continuing evolutionary saga
- (2012) Jonathan P. Stoye NATURE REVIEWS MICROBIOLOGY
- An anti-PR1/HLA-A2 T-cell receptor-like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells
- (2011) A. Sergeeva et al. BLOOD
- Chronic Virus Infection Enforces Demethylation of the Locus that Encodes PD-1 in Antigen-Specific CD8+ T Cells
- (2011) Ben Youngblood et al. IMMUNITY
- Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate- or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group
- (2011) Michael Lübbert et al. JOURNAL OF CLINICAL ONCOLOGY
- Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non-Small Cell Lung Cancer
- (2011) R. A. Juergens et al. Cancer Discovery
- Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia
- (2010) O. Goodyear et al. BLOOD
- Regulation of cancer germline antigen gene expression: implications for cancer immunotherapy
- (2010) Stacey N Akers et al. Future Oncology
- The DNA demethylating agent 5-aza-2′-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cells
- (2010) Maika Almstedt et al. LEUKEMIA RESEARCH
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
- (2009) H. Dohner et al. BLOOD
- Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2′-deoxycytidine
- (2009) Irina Daurkin et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005
- (2008) A. R. Derolf et al. BLOOD
- Immune modulation and chronic graft-versus-host disease
- (2008) R J Soiffer BONE MARROW TRANSPLANTATION
- Intertumor and Intratumor NY-ESO-1 Expression Heterogeneity Is Associated with Promoter-Specific and Global DNA Methylation Status in Ovarian Cancer
- (2008) A. Woloszynska-Read et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started